Navigation Links
Symposium honoring UD Nobel Laureate Richard Heck set for May 26
Date:3/3/2011

sor of Chemistry at Purdue University, who will deliver the keynote address as the 2011 Heck Lecturer.

Other speakers include Stephen L. Buchwald, Camille Dreyfus Professor of Chemistry at the Massachusetts Institute of Technology; Todd Nelson, director of pharmaceutical sciences at Merck; Melanie Sanford, professor of chemistry at the University of Michigan; Victor Snieckus, Bader Chair in Organic Chemistry at Queen's University; and Dean Toste, professor of chemistry at the University of California Berkeley.

Primary sponsors include the University of Delaware through the Provost's Office, the College of Arts and Sciences, and the Department of Chemistry and Biochemistry; Dow Chemical Co.; and Ashland. Additional support is being provided by DuPont.

Richard Heck was born in Springfield, Mass., on Aug. 15, 1931. He completed both his bachelor of science degree (1952) and his doctorate (1954) at the University of California Los Angeles (UCLA).

After postdoctoral work, he took a position with Hercules in Wilmington, Del., in 1957, and moved to the University of Delaware in 1971, where he remained until his retirement in 1989. He now lives in the Philippines.

Heck's contributions previously have been recognized through a number of prestigious awards. In 2004, the University of Delaware Department of Chemistry and Biochemistry established the Heck Lectureship, an annual award given in recognition of significant achievement in the field of organometallic chemistry. In 2005, he was awarded the Wallace H. Carothers Award, bestowed by the Delaware section of the American Chemical Society for creative applications of chemistry that have had substantial commercial impact. In 2006, he received the Herbert C. Brown Award for Creative Research in Synthetic Methods from the American Chemical Society.


'/>"/>

Contact: Tracey Bryant
tbryant@udel.edu
302-831-8185
University of Delaware
Source:Eurekalert

Page: 1 2

Related biology news :

1. Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium
2. AAAS Symposium: New research facilitates scientific knowledge transfer
3. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
4. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
5. Symposium to provide forum for best pre-clinical and translational bone research
6. Oil spill symposium to convene scientists, media, policymakers and community leaders
7. Graduate physics students wins top honors in superconductivity symposium
8. Symposium marks milestones in honey bee management, research
9. CTRC-AACR to hold 33rd Annual San Antonio Breast Cancer Symposium
10. Symposium in Vietnam to discuss integrated approach to defeating diarrheal disease
11. Abstracts for the EORTC-NCI-AACR Symposium in Berlin go up online on Friday, Oct. 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has announced ... 2015-2019" report to their offering. The ... at a CAGR of 23.5 percent over the period ... and the growth prospects of the Global Iris Recognition ... size, the report considers the revenue generated from sales ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... CORVALLIS, Ore. A new study by Oregon State ... often know what kinds of foods they should be eating, ... money for meals. Joan Gross and Nancy Rosenberger, both ... rural Oregonians living in poverty by conducting in-depth interviews with ...
... it is for pregnant women to eat good, nutritious food. ... children who are less likely to develop type 1 diabetes, ... at the University of Gothenburg, Sweden. The ... conducting a population study called ABIS (All Babies in Southeast ...
... Ala. An experimental drug cocktail that includes ... hope in developing a single agent to treat ... in the University of Alabama Birmingham (UAB) Division ... the triple combination of oseltamivir (Tamiflu), amantadine (Symmetrel) ...
Cached Biology News:Poor in rural Oregon face 'double binds' when getting food 2Poor in rural Oregon face 'double binds' when getting food 3Vegetables can protect unborn child against diabetes 2Triple-combo drug shows promise against antiviral-resistant H1N1, UAB researcher says 2
(Date:4/16/2015)...  AnaptysBio, Inc., a leader in the ... announced the advancement of its first-in-class anti-interleukin-36 ... The Company,s anti-IL-36R therapeutic antibody, called ANB019, ... psoriasis (GPP), an orphan systemic inflammatory disease ... owned within AnaptysBio,s proprietary antibody pipeline and ...
(Date:4/16/2015)... 16, 2015  EMD Serono today announced the ... Germany , appointed Alise Reicin ... Global Clinical Development.  Dr. Reicin brings extensive research ... Oncology and Immunology. She is an accomplished pharmaceutical ... a Vice President in various capacities across R&D ...
(Date:4/16/2015)... 16, 2015 Fairleigh Dickinson University ... Gulfo to become the Executive Director of the ... announced the kick-off of the Initiative for Patient ... Dr. Gulfo, under the Rothman Institute of Innovation ... and in collaboration with FDU’s School of Pharmacy’s ...
(Date:4/16/2015)... Modality Solutions, a company that delivers ... industries, is pleased to announce its President, Gary ... Cold Chain IQ - Temperature Control Logistics and ... Global Cold Chain Connections, is dedicated to sharing ... pharmaceutical and healthcare supply chains. , Cold ...
Breaking Biology Technology:AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 2Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 3
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a ... small molecule therapeutics for,the treatment of cancer, today ... JMP Securities Healthcare Focus Conference in Boston. ... p.m. (Eastern) on,Tuesday, November 13, 2007. There will ...
... ... treatment issues, SAN RAMON, Calif., Nov. 7 ... advisory group,designed to tackle head-on the increasingly complex ethical issues of,infertility medicine ... RSC,s ethics committee, believed to be the second of its kind among,infertility ...
... SyntheMed, Inc. (OTC,Bulletin Board: SYMD), a biomaterials ... tissue repair and drug delivery,products, announced today that ... the Securities and Exchange Commission (SEC) that, if,declared ... sell, from time to,time, up to $20 million ...
Cached Biology Technology:Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference 2California IVF Experts Tap Ethics Committee for Guidance 2SyntheMed Files Universal Shelf Registration 2
... • Enzyme concentration - 5 units/µL ,• ... higher yields ,• Leaves an 'A' overhang ... polymerase which exhibits very high activity in ... To ensure the quality of the enzyme, ...
... Recombinant DNA polymerase from Thermus aquaticus expressed ... contamination; 1 tube of 250 units enzyme/tube ... (Low DNA), is the same enzyme as ... through a proprietary separation process to ensure ...
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
Taq DNA polymerase, 10,000U...
Biology Products: